We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SHEL:LSEShell Plc Analysis

Data as of 2026-08-10 - not real-time

£3,277.50

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Shell plc is priced at £3,277.50 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it gained 13.1%. With RSI at 54.3 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at £2,643.00 and resistance at £3,421.00.
Multiples put this in undervalued territory: 9.8 times earnings against the sector's 19.4. Analyst price targets sit 13.4% above the current price. Revenue is growing at 44.7% on a 8.8% profit margin. The 3.59% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 23.6%, a beta of -0.14 and a maximum drawdown of 19.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.

Top Market Events

TotalEnergies EU:TTE has agreed to acquire Shell’s LSE:SHEL onshore renewable energy business in Europe while...Shell plc NYSE:SHEL is one of the 9 Most Oversold Strong Buy-Rated Stocks to Invest In Now.Shell plc NYSE:SHEL is one of the 10 integrated oil and gas companies to invest in according to hedge funds.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 3035.16
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 9.8 versus sector average of 19.4
  • Trading above the 200-day average of 3035.16

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 9.8 versus sector average of 19.4
  • Analyst targets imply +13.4% versus the current price
  • Revenue growth of +44.7%

Key Metrics & Analysis

Financial Health

Revenue Growth44.70%
Profit Margin8.76%
P/E Ratio9.8
ROE14.34%
ROA6.40%
Debt/Equity40.20
P/B Ratio1.4
Op. Cash Flow£49.1B
Free Cash Flow£21.5B
Industry P/E19.4

Technical Analysis

TrendBullish
RSI54.3
Support£2,643.00
Resistance£3,421.00
MA 20£3,266.73
MA 50£3,142.66
MA 200£3,035.16
MACDBearish
VolumeStable
Fear & Greed Index94.82

Valuation

Fair Value£12,803.90
Target Price£3,715.80
Upside/Downside13.37%
GradeUndervalued
TypeValue
Dividend Yield3.59%

Risk Assessment

Beta-0.14
Volatility23.57%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.